ME-401
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for ME-401, covering 2025-02-07 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's Lymphoma [Phase 1]